跳至主要内容
临床试验/NCT02757430
NCT02757430已完成不适用

EnSite Precision™ Cardiac Mapping System and EnSite Precision™ Software v2.0 Observational Registry

Abbott Medical Devices1 个研究点 分布在 1 个国家目标入组 515 人开始时间: 2016年8月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
515
试验地点
1
主要终点
Assessment of the EnSite Precision™ Software V2.0 in Terms of Geometry Accuracy

研究概览

简要总结

The objective of this registry is to assess and characterize the use and performance of the EnSite Precision™ Cardiac Mapping System and the EnSite Precision™ Software V2.0 in a variety of electrophysiological (EP) procedures and clinical settings. This registry will assess the clinical performance of the system in a controlled, real-world environment after commercial release.

Up to 500 subjects will be enrolled in up to 50 sites worldwide.

Data will be collected at enrollment/baseline, procedure and pre-discharge. There is no long-term follow-up required for this registry.

The anticipated registry enrollment is about 6-7 months.

详细描述

The use of the EnSite Precision™ Cardiac Mapping System will be assessed by collecting feedback from physicians/operators through specific questions.

The performance of the EnSite Precision™ Cardiac Mapping System will be assessed by collecting procedure data and adverse events.

A detailed Data Management Plan will be established to ensure consistency of the data. This document will include procedures used for data review, database cleaning, and issuing and resolving data queries. If appropriate, the Data Management Plan may be updated throughout the registry duration. All revisions will be tracked and document controlled.

Case Report Form data will be captured in a validated electronic database management system hosted by St. Jude Medical.

Centralized monitoring will occur through routine internal data review. This monitoring is designed to identify missing and inconsistent data, data outliers, and potential protocol deviations that may be indicative of site non-compliance. On-site monitoring may occur at the discretion of the sponsor.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients indicated for a cardiac EP study and ablation procedure using a 3D mapping system
  • Over 18 years of age
  • Ability to provide informed consent for registry participation and be willing and able to comply with the protocol described evaluations

排除标准

  • Contraindication to anticoagulation
  • Presence of thrombus
  • Implanted with mechanical prosthetic heart valve
  • Recent (<3 months) myocardial Infarction or unstable angina or coronary artery by-pass
  • Pregnant or nursing
  • Individuals whose willingness to volunteer in a registry, in the judgment of investigator or public authorities, could be unduly influenced by lack of or loss of the autonomy due to immaturity, or mental disability, or adverse personal circumstances, or hierarchical influence

结局指标

主要结局

Assessment of the EnSite Precision™ Software V2.0 in Terms of Geometry Accuracy

时间窗: during procedure

summarizing the count and percentage of patients with accurate geometry

Mapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters

时间窗: during procedure

mapping time will be summarized (using mean and standard deviation across arrhythmia types, and for each type of arrhythmia as appropriate) for the following modules: Manual AutoMap™ TurboMap™

Mapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With Manual Mapping

时间窗: during procedure

mapping time will be summarized (using mean and standard deviation across arrhythmia types, and for each type of arrhythmia as appropriate) for the following modules: Manual

Mapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With AutoMap Module Mapping

时间窗: during procedure

mapping time will be summarized (using mean and standard deviation across arrhythmia types, and for each type of arrhythmia as appropriate) for the following modules: AutoMap module

Mapping Time Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters With TurboMap Module Mapping

时间窗: during procedure

mapping time will be summarized (using mean and standard deviation across arrhythmia types, and for each type of arrhythmia as appropriate) for the following modules: TurboMap module

Point Density Associated With (re-)Mapping One or Multiple Arrhythmias in a Single Subject With a Variety of Catheters

时间窗: during procedure

mapping points collected and used will be summarized (using mean and standard deviation across arrhythmia types, and for each type of arrhythmia as appropriate)

Assessment of the EnSite Precision™ Software V2.0 in Terms of System Stability

时间窗: during procedure

summarizing the count and percentage of patients with overall system stability

Assessment of the EnSite Precision™ Software V2.0 in Terms of Unrecoverable Shifts

时间窗: during procedure

summarizing the count and percentage of patients with unrecoverable shifts

次要结局

  • EnSite Precision™ Cardiac Mapping System Assessment(during procedure)
  • Clinical Utility and Ease of Use of the Automated Radiofrequency Marker Placement(during procedure)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验